ABILIFY- aripiprazole tablet ABILIFY- aripiprazole solution ABILIFY- aripiprazole tablet, orally disintegrating ABILIFY- arip Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

abilify- aripiprazole tablet abilify- aripiprazole solution abilify- aripiprazole tablet, orally disintegrating abilify- arip

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

SAMSCA tolvaptan 15 mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

samsca tolvaptan 15 mg tablet blister pack

otsuka australia pharmaceutical pty ltd - tolvaptan, quantity: 15 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; microcrystalline cellulose; indigo carmine aluminium lake; lactose monohydrate; maize starch - samsca is indicated for the treatment of clinically significant hypervolemic or euvolemic hyponatremia (serum sodium less than 125 mmol/l, or less marked hyponatremia that is symptomatic and has resisted correction with fluid restriction) including patients with heart failure and syndrome of inappropriate antidiuretic hormone (siadh).

SAMSCA TABLET 15MG Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

samsca tablet 15mg

otsuka pharmaceuticals (singapore) pte. ltd. - tolvaptan - tablet - tolvaptan 15mg

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

inqovi 35/100 decitabine 35 mg and cedazuridine 100 mg tablet blister pack

otsuka australia pharmaceutical pty ltd - decitabine, quantity: 35 mg; cedazuridine, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - inqovi 35/100 is indicated for the treatment of adult patients with myelodysplastic syndromes (mds) intermediate-1, intermediate-2, and high-risk international prognostic scoring system groups, and patients with chronic myelomonocytic leukaemia (cmml).

INQOVI 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

inqovi 35/100 decitabine 35 mg and cedazuridine 100 mg tablet bottle

otsuka australia pharmaceutical pty ltd - decitabine, quantity: 35 mg; cedazuridine, quantity: 100 mg - tablet, film coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium; hypromellose; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350 - inqovi 35/100 is indicated for the treatment of adult patients with myelodysplastic syndromes (mds) intermediate-1, intermediate-2, and high-risk international prognostic scoring system groups, and patients with chronic myelomonocytic leukaemia (cmml).

INQOVI TABLET Կանադա - անգլերեն - Health Canada

inqovi tablet

otsuka pharmaceutical co ltd - decitabine; cedazuridine - tablet - 35mg; 100mg - decitabine 35mg; cedazuridine 100mg - antineoplastic agents

DACOGEN POWDER Կանադա - անգլերեն - Health Canada

dacogen powder

otsuka pharmaceutical co ltd - decitabine - powder - 50mg - decitabine 50mg - antineoplastic agents

ABILIFY ORAL SOLUTION 1MGML Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

abilify oral solution 1mgml

otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - solution - aripiprazole 1.0 mg/ml

ABILIFY TABLET 2MG Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

abilify tablet 2mg

otsuka pharmaceuticals (singapore) pte. ltd. - aripiprazole - tablet - aripiprazole 2mg

DEXTROSE INJ 5% BP (1000ML PC) Մալայզիա - անգլերեն - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

dextrose inj 5% bp (1000ml pc)

luen wah medical co. sdn. bhd. - dextrose, anhydrous/anhydrous glucose -